|
|
||||||||
The FASEB Journal, Vol 6, 3275-3282, Copyright © 1992 by The Federation of American Societies for Experimental Biology
REVIEWS |
A Levitzki
Department of Biological Chemistry, Alexander Silberman Institute of Life Sciences, Hebrew University of Jerusalem, Israel.
Protein tyrosine kinases (PTKs) are members of a growing family of oncoproteins and protooncoproteins that play a pivotal role in normal and abnormal proliferative processes. This hallmark identifies these unique proteins as potential targets for antiproliferative therapy. This review discusses the current status of PTK inhibitors, with special emphasis on tyrphostins as antiproliferative agents and as potential drugs for cancers, leukemias, psoriasis, and restenosis as well as other proliferative conditions. The development of tyrphostins as selective signal blockers can be viewed as a first step toward the development of "smart" cocktails as antiproliferative agents. Each of these custom-made cocktails will be aimed at proliferative conditions whose transduction pathways can be characterized by molecular tools. The review also discusses the use of PTK blockers as tools to study signal transduction processes in which protein tyrosine kinases are implicated.
This article has been cited by other articles:
![]() |
S. Verstovsek, T. Manshouri, A. Quintas-Cardama, D. Harris, J. Cortes, F. J. Giles, H. Kantarjian, W. Priebe, and Z. Estrov WP1066, a Novel JAK2 Inhibitor, Suppresses Proliferation and Induces Apoptosis in Erythroid Human Cells Carrying the JAK2 V617F Mutation Clin. Cancer Res., February 1, 2008; 14(3): 788 - 796. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ferrajoli, S. Faderl, Q. Van, P. Koch, D. Harris, Z. Liu, I. Hazan-Halevy, Y. Wang, H. M. Kantarjian, W. Priebe, et al. WP1066 Disrupts Janus Kinase-2 and Induces Caspase-Dependent Apoptosis in Acute Myelogenous Leukemia Cells Cancer Res., December 1, 2007; 67(23): 11291 - 11299. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Lipson and S. G. Clarke S-Adenosylmethionine-dependent Protein Methylation in Mammalian Cytosol via Tyrphostin Modification by Catechol-O-methyltransferase J. Biol. Chem., October 19, 2007; 282(42): 31094 - 31102. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Stockwin, M. A. Bumke, S. X. Yu, S. P. Webb, J. R. Collins, M. G. Hollingshead, and D. L. Newton Proteomic Analysis Identifies Oxidative Stress Induction by Adaphostin Clin. Cancer Res., June 15, 2007; 13(12): 3667 - 3681. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Levitzki Signal Transduction Therapy of Cancer from Concept to Clinic: Promises and Hurdles Am. Assoc. Cancer Res. Educ. Book, April 14, 2007; 2007(1): 45 - 48. [Full Text] [PDF] |
||||
![]() |
T. D. Shanafelt, Y. K. Lee, N. D. Bone, A. K. Strege, V. L. Narayanan, E. A. Sausville, S. M. Geyer, S. H. Kaufmann, and N. E. Kay Adaphostin-induced apoptosis in CLL B cells is associated with induction of oxidative stress and exhibits synergy with fludarabine Blood, March 1, 2005; 105(5): 2099 - 2106. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Khan, H. H. Cheung, E. R. Gillard, J. A. Palarca, D. S. Welsbie, J. W. Gurd, and B. G. Stanley Lateral Hypothalamic Signaling Mechanisms Underlying Feeding Stimulation: Differential Contributions of Src Family Tyrosine Kinases to Feeding Triggered Either by NMDA Injection or by Food Deprivation J. Neurosci., November 24, 2004; 24(47): 10603 - 10615. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bendetz-Nezer, A. Gazit, and E. Priel DNA Topoisomerase I As One of the Cellular Targets of Certain Tyrphostin Derivatives Mol. Pharmacol., September 1, 2004; 66(3): 627 - 634. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Shushan, N. Rojansky, N. Laufer, B. Y. Klein, Z. Shlomai, R. Levitzki, Z. Hartzstark, and H. Ben-Bassat The AG1478 tyrosine kinase inhibitor is an effective suppressor of leiomyoma cell growth Hum. Reprod., September 1, 2004; 19(9): 1957 - 1967. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-D. Way, M.-C. Kao, and J.-K. Lin Apigenin Induces Apoptosis through Proteasomal Degradation of HER2/neu in HER2/neu-overexpressing Breast Cancer Cells via the Phosphatidylinositol 3-Kinase/Akt-dependent Pathway J. Biol. Chem., February 6, 2004; 279(6): 4479 - 4489. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Rodrigo, D. S. Martin, and K. M. Eyster Estrogen decreases biglycan mRNA expression in resistance blood vessels Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2003; 285(4): R754 - R761. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Tapia, L. J. Garcia-Marin, and R. T. Jensen Cholecystokinin-stimulated Protein Kinase C-{delta} Kinase Activation, Tyrosine Phosphorylation, and Translocation Are Mediated by Src Tyrosine Kinases in Pancreatic Acinar Cells J. Biol. Chem., September 12, 2003; 278(37): 35220 - 35230. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Ravandi, M. Talpaz, and Z. Estrov Modulation of Cellular Signaling Pathways: Prospects for Targeted Therapy in Hematological Malignancies Clin. Cancer Res., February 1, 2003; 9(2): 535 - 550. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Alas and B. Bonavida Inhibition of Constitutive STAT3 Activity Sensitizes Resistant Non-Hodgkin's Lymphoma and Multiple Myeloma to Chemotherapeutic Drug-mediated Apoptosis Clin. Cancer Res., January 1, 2003; 9(1): 316 - 326. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ben-Bassat, Z. Hartzstark, R. Levitzki, B. Y. Klein, Z. Shlomai, A. Gazit, and A. Levitzki Tyrosine Kinase Inhibitors Suppress the Growth of Non-Hodgkin B Lymphomas J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 163 - 171. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. F. Mow, J. Chandra, P. A. Svingen, C. G. Hallgren, E. Weisberg, T. J. Kottke, V. L. Narayanan, M. R. Litzow, J. D. Griffin, E. A. Sausville, et al. Effects of the Bcr/abl kinase inhibitors STI571 and adaphostin (NSC 680410) on chronic myelogenous leukemia cells in vitro Blood, January 15, 2002; 99(2): 664 - 671. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Middleton Jr., C. Kandaswami, and T. C. Theoharides The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer Pharmacol. Rev., December 1, 2000; 52(4): 673 - 751. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Zieske, H. Takahashi, A. E. K. Hutcheon, and A. C. Dalbone Activation of Epidermal Growth Factor Receptor during Corneal Epithelial Migration Invest. Ophthalmol. Vis. Sci., May 1, 2000; 41(6): 1346 - 1355. [Abstract] [Full Text] |
||||
![]() |
I. Fishbein, J. Waltenberger, S. Banai, L. Rabinovich, M. Chorny, A. Levitzki, A. Gazit, R. Huber, U. Mayr, S. D. Gertz, et al. Local Delivery of Platelet-Derived Growth Factor Receptor-Specific Tyrphostin Inhibits Neointimal Formation in Rats Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20(3): 667 - 676. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Jaszewski, A. Khan, F. H. Sarkar, O. Kucuk, M. Tobi, A. Zagnoon, R. Dhar, J. Kinzie, and A. P. N. Majumdar Folic acid inhibition of EGFR-mediated proliferation in human colon cancer cell lines Am J Physiol Cell Physiol, December 1, 1999; 277(6): C1142 - C1148. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Neugarten, I. Medve, J. Lei, and S. R. Silbiger Estradiol suppresses mesangial cell type I collagen synthesis via activation of the MAP kinase cascade Am J Physiol Renal Physiol, December 1, 1999; 277(6): F875 - F881. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Taskinen, M. Toth, O. Vuolteenaho, J. Magga, and H. Ruskoaho Inhibition of Atrial Wall Stretch-Induced Cardiac Hormone Secretion by Lavendustin A, a Potent Tyrosine Kinase Inhibitor Endocrinology, September 1, 1999; 140(9): 4198 - 4207. [Abstract] [Full Text] |
||||
![]() |
C. Carlo-Stella, E. Regazzi, G. Sammarelli, S. Colla, D. Garau, A. Gazit, B. Savoldo, D. Cilloni, A. Tabilio, A. Levitzki, et al. Effects of the Tyrosine Kinase Inhibitor AG957 and an Anti-Fas Receptor Antibody on CD34+ Chronic Myelogenous Leukemia Progenitor Cells Blood, June 1, 1999; 93(11): 3973 - 3982. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Bright, C. Du, and S. Sriram Tyrphostin B42 Inhibits IL-12-Induced Tyrosine Phosphorylation and Activation of Janus Kinase-2 and Prevents Experimental Allergic Encephalomyelitis J. Immunol., May 15, 1999; 162(10): 6255 - 6262. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Palmier, M. Vacher, S. Harbon, and D. Leiber A Tyrosine Kinase Signaling Pathway, Regulated by Calcium Entry and Dissociated from Tyrosine Phosphorylation of Phospholipase Cgamma -1, Is Involved in Inositol Phosphate Production by Activated G Protein-Coupled Receptors in Myometrium J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 1022 - 1030. [Abstract] [Full Text] |
||||
![]() |
A. Renglin, A.-S. Harmala-Brasken, J. E. Eriksson, and A. Onfelt Mitotic aberrations induced by carbaryl reflect tyrosine kinase inhibition with coincident up-regulation of serine/threonine protein phosphatase activity: implications for coordination of karyokinesis and cytokinesis Mutagenesis, May 1, 1999; 14(3): 327 - 333. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fang, E Ionides, G Oster, R Nuccitelli, and R. Isseroff Epidermal growth factor receptor relocalization and kinase activity are necessary for directional migration of keratinocytes in DC electric fields J. Cell Sci., January 6, 1999; 112(12): 1967 - 1978. [Abstract] [PDF] |
||||
![]() |
L. Liu, J. R. Turner, Y. Yu, A. J. Khan, R. Jaszewski, S. E. G. Fligiel, and A. P. N. Majumdar Differential expression of EGFR during early reparative phase of the gastric mucosa between young and aged rats Am J Physiol Gastrointest Liver Physiol, November 1, 1998; 275(5): G943 - G950. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Freitas, S. R. Dalmau, and W. Savino Epidermal Growth Factor (EGF) Modulates Fetal Thymocyte Growth and Differentiation: Partial Reversal by Insulin, Mimicking by Specific Inhibitors of EGF Receptor Tyrosine Kinase Activity, and Differential Expression of CD45 Phosphatase Isotypes J. Immunol., October 1, 1998; 161(7): 3384 - 3392. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Calautti, S. Cabodi, P. L. Stein, M. Hatzfeld, N. Kedersha, and G. Paolo Dotto Tyrosine Phosphorylation and Src Family Kinases Control Keratinocyte Cell-Cell Adhesion J. Cell Biol., June 15, 1998; 141(6): 1449 - 1465. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Efstathiou, M. Noda, A. Rowan, C. Dixon, R. Chinery, A. Jawhari, T. Hattori, N. A. Wright, W. F. Bodmer, and M. Pignatelli Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells PNAS, March 17, 1998; 95(6): 3122 - 3127. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Kelly, P. J. Goldschmidt-Clermont, E. E. Milliken, T. Arai, E. H. Smith, and G. B. Bulkley Protein tyrosine phosphorylation mediates TNF-induced endothelial-neutrophil adhesion in vitro Am J Physiol Heart Circ Physiol, February 1, 1998; 274(2): H513 - H519. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Touyz and E. L. Schiffrin Angiotensin II Regulates Vascular Smooth Muscle Cell pH, Contraction, and Growth Via Tyrosine Kinase–Dependent Signaling Pathways Hypertension, August 1, 1997; 30(2): 222 - 229. [Abstract] [Full Text] |
||||
![]() |
X.-L. Zheng, S. Mokashi, and M. D. Hollenberg Contractile Action of Ethanol in Guinea Pig Gastric Smooth Muscle: Inhibition by Tyrosine Kinase Inhibitors and Comparison with the Contractile Action of Epidermal Growth Factor-Urogastrone J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 485 - 495. [Abstract] [Full Text] |
||||
![]() |
M. Yanabu, Y. Ozaki, S. Nomura, T. Miyake, Y. Miyazaki, H. Kagawa, Y. Yamanaka, N. Asazuma, K. Satoh, S. Kume, et al. Tyrosine Phosphorylation and p72syk Activation by an Anti-Glycoprotein Ib Monoclonal Antibody Blood, March 1, 1997; 89(5): 1590 - 1598. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Biener, R. Feinstein, M. Mayak, Y. Kaburagi, T. Kadowaki, and Y. Zick Annexin II Is a Novel Player in Insulin Signal Transduction. POSSIBLE ASSOCIATION BETWEEN ANNEXIN II PHOSPHORYLATION AND INSULIN RECEPTOR INTERNALIZATION J. Biol. Chem., November 15, 1996; 271(46): 29489 - 29496. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Hanke, J. P. Gardner, R. L. Dow, P. S. Changelian, W. H. Brissette, E. J. Weringer, B. A. Pollok, and P. A. Connelly Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase Inhibitor J. Biol. Chem., January 12, 1996; 271(2): 695 - 701. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Seger, Y. Biener, R. Feinstein, T. Hanoch, A. Gazit, and Y. Zick Differential Activation of Mitogen-activated Protein Kinase and S6 Kinase Signaling Pathways by 12-O-Tetradecanoylphorbol-13-acetate (TPA) and Insulin J. Biol. Chem., November 24, 1995; 270(47): 28325 - 28330. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Slack, J. Breu, M. A. Petryniak, K. Srivastava, and R. J. Wurtman Tyrosine Phosphorylation-dependent Stimulation of Amyloid Precursor Protein Secretion by the m3 Muscarinic Acetylcholine Receptor J. Biol. Chem., April 7, 1995; 270(14): 8337 - 8344. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Levitzki and A Gazit Tyrosine kinase inhibition: an approach to drug development Science, March 24, 1995; 267(5205): 1782 - 1788. [Abstract] [PDF] |
||||
![]() |
E. R. Sjoberg, R. Chammas, H. Ozawa, I. Kawashima, K.-H. Khoo, H. R. Morris, A. Dell, T. Tai, and A. Varki Expression of De-N-acetyl-gangliosides in Human Melanoma Cells Is Induced by Genistein or Nocodazole J. Biol. Chem., February 17, 1995; 270(7): 2921 - 2930. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rezzonico, G. Ponzio, A.ès Loubat, D. Lallemand, A. Proudfoot, and B. Rossi Two Distinct Signalling Pathways Are Involved in the Control of the Biphasic junB Transcription Induced by Interleukin-6 in the B Cell Hybridoma 7TD1 J. Biol. Chem., January 20, 1995; 270(3): 1261 - 1268. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Novogrodsky, A Vanichkin, M Patya, A Gazit, N Osherov, and A Levitzki Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors Science, May 27, 1994; 264(5163): 1319 - 1322. [Abstract] [PDF] |
||||
![]() |
M. P. Fadel, M. Szewczenko-Pawlikowski, P. Leclerc, E. Dziak, J. M. Symonds, O. Blaschuk, M. Michalak, and M. Opas Calreticulin Affects beta -Catenin-associated Pathways J. Biol. Chem., July 13, 2001; 276(29): 27083 - 27089. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |